Melanoma Advances: Where We Are and Where We're Going
Combination therapy has been the biggest recent advance in the melanoma space, but there is still more work to be done, according to Douglas B. Johnson, MD.
Relacorilant/Nab-Paclitaxel Is Convenient, Safe in Ovarian Cancer
Neoadjuvant Nivolumab Regimen Improves OS in Resectable NSCLC
Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer
Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care